p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins

SIMPLE SUMMARY: The humoral immune response in cancer has been demonstrated to be useful for distinguishing patients from healthy individuals using serum or plasma. Our study aimed to assess whether p53 and p63 proteoforms derived from alternative splicing could have a differential seroreactivity an...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero-Calle, Ana, Garranzo-Asensio, María, Torrente-Rodríguez, Rebeca M., Ruiz-Valdepeñas Montiel, Víctor, Poves, Carmen, Dziaková, Jana, Sanz, Rodrigo, Díaz del Arco, Cristina, Pingarrón, José Manuel, Fernández-Aceñero, María Jesús, Campuzano, Susana, Barderas, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092954/
https://www.ncbi.nlm.nih.gov/pubmed/37046764
http://dx.doi.org/10.3390/cancers15072102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092954/
https://www.ncbi.nlm.nih.gov/pubmed/37046764
http://dx.doi.org/10.3390/cancers15072102

Ejemplares similares